V. Yau

Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy

A. Bezjak, A. Hope, P. Lindsay, 2017, Clinical lung cancer.

Reasons for poor accrual in palliative radiation therapy research studies.

C. Hayter, M. Tsao, E. Chow, 2006, Supportive cancer therapy.

Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single‐Institution Experience

A. Bezjak, A. Hope, A. Sun, 2018, Clinical lung cancer.

Debate: single-fraction treatment should be standard in the retreatment of uncomplicated bone metastases.

H. Soliman, D. Tsang, M. Tsao, 2015, Annals of palliative medicine.

Pain management in cancer patients with bone metastases remains a challenge.

E. Chow, L. Holden, C. Danjoux, 2004, Journal of pain and symptom management.

SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial.

A. Louie, D. Palma, H. Bahig, 2018, Clinical lung cancer.

Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative?

A. Bezjak, A. Hope, P. Lindsay, 2018, International journal of radiation oncology, biology, physics.

Chronic lymphocytic leukemia resembling metastatic bone disease-- an unusual manifestation.

M. Christakis, E. Chow, N. Ismiil, 2003, Journal of Pain and Symptom Management.